JW Kolaczynski, JF Caro - Annals of internal medicine, 1994 - Am Coll Physicians Purpose: To review the effects of insulin-like growth factor-1 (IGF-1) and to
discuss the clinical benefits and risks of using it in patients with diabetes. ... Data Sources: Recent publications identified through a MEDLINE search ... Cited by 42 - Related articles - BL Direct - All 4 versions
E Conti, F Andreotti, A Sestito, P Riccardi, E … - The American journal of cardiology, 2002 - Elsevier Insulin-like growth factor-1 (IGF-1) is synthesized by the liver and kidneys,
and also as a paracrine and autocrine substance by endothelial cells and by
vascular and cardiac myocytes.[1 and 2] It has been well established that ... Cited by 19 - Related articles - BL Direct - All 8 versions
- ►synviswin.com [PDF] LE Wold, D Muralikrishnan, CB Albano, FL … - Acta Diabetologica, 2003 - Springer Abstract Diabetes, which causes enhanced oxidative stress, is a multifactorial
disease that leads to deleterious effects in many organ systems within the body.
Ubiquinones (coen- zyme Q 9 and Q 10 ) are amphipathic molecular components ... Cited by 6 - Related articles - BL Direct - All 6 versions
[CITATION] Insulin, insulin-like growth factors, and their receptors
N Ruderman, AC Moses, DE Moller - The liver: biology and pathobiology. 3rd ed. New York: …, 1994 Cited by 7 - Related articles
DS Schalch, NJ Turman, VS Marcsisin, M … - Journal of Clinical Endocrinology & Metabolism, 1993 - Endocrine Soc Page 1. 0021-972x/93/77@3-1563$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright 0 1993 by The Endocrine Society Vol. 17, No. 6 Printed in USA ... Cited by 40 - Related articles - BL Direct - All 4 versions
KE Innes, L Weitzel, M Laudenslager - Gynecol Obstet Invest, 2005 - content.karger.com Women with a history of preeclampsia are at increased risk of developing
cardiovascular disorders later in life [1–4] . Several recent studies suggest
that prior preeclamp- sia is also associated with lower lifetime breast ... Cited by 10 - Related articles - BL Direct - All 7 versions
R Laager, U Keller - Diabetologia, 1993 - Springer Summary. Insulin-like growth factor I (65 gg/kg) or insulin (0.1 IU/kg) were
injected iv on two separate occasions in random order in normal and in Type 2
(non-insulin-depen- dent) diabetic subjects. Insulin-like growth factor I ... Cited by 10 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] PD Zenobi, SE Jaeggi-Groisman, WF Riesen, … - Journal of Clinical Investigation, 1992 - pubmedcentral.nih.gov Hyperglycemia, hyperinsulinemia, and insulin resistance cause vascular disease
in type 2 diabetes mellitus. Dietary treatment alone often fails and oral drugs
or insulin enhance hyperinsulin- emia. In previous studies, an intravenous ... Cited by 99 - Related articles - BL Direct - All 7 versions
MK Sinha, C Buchanan, N Leggett, L Martin, … - Diabetes, 1989 - Am Diabetes Assoc We demonstrate the presence of specific insulinlike growth factor I (IGF-I)
receptors in human adipocytes. Competition studies with 125I-labeled IGF-I and
unlabeled IGF-I, IGF-II, and insulin showed the specificity of 125I-IGF-I ... Cited by 32 - Related articles - All 4 versions
AL Usala, T Madigan, B Burguera, W Cefalu, … - Journal of Clinical Endocrinology & Metabolism, 1994 - Endocrine Soc Page 1. GiI21-972x/94/7902-0435$03.00/0 Journal of Clinical Endocrmology and Metabolism
Copyright 0 1994 by The Endocrine Society Vol. 79, No. 2 Printed in USA ... Cited by 15 - Related articles - BL Direct - All 4 versions
